Sign in
4

Changes in Ownership

Amneal Pharmaceuticals, Inc. Filed Acc 0001628280-26-032911

Director acquired 34,819 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Kiely John Director 2026-05-07 Option exercise +34,819 260,252 D
Derivatives
Kiely John Director 2026-05-07 Option exercise · Restricted Stock Units −34,819 0 D
Kiely John Director 2026-05-06 Grant or award · Restricted Stock Units +19,824 19,824 D
Loading xslF345X06/wk-form4_1778271857.xml…